Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
Clinical trial NCT03578822 · COMPLETED
Trial details
- NCT number
- NCT03578822
- Sponsor
- Tasly Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-10
- Primary completion
- 2020-02-28
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.